The Department of Biomedicine (DBM) integrates basic and clinical researchers from University of Basel and University Hospitals committed to deepen the understanding of health and disease while driving the development of innovative therapies that address unmet medical needs.
With over 70 research groups and 800 employees, the Department of Biomedicine is the largest department within the University of Basel. Be part of our future!
As a postdoctoral researcher, you will become part of a young team working on cancer stem cells and the molecular mechanisms of their regulation – a highly dynamic and inspiring field of research where groundbreaking discoveries are still to be made.
The working place of the successful candidate is the Department of Biomedicine at Mattenstrasse 28, 4057 Basel.
Scientific Background
Stem cells are rare populations of cells that (in their primordial, i.e., ontological significance) serve as clonal founders of embryonic or adult somatic structures, while retaining a largely undifferentiated status themselves. Although dependent on tissue context, a recurrent feature of stem cells is the expression of pluripotency-inducing transcription factors, such as OCT4, KLF4, c-MYC, and SOX2. It is this set of four (or subsets of which, under certain conditions) that is indeed capable of reprogramming adult body cells into conditions of induced pluripotency. Dysregulation of pluripotency factors, on the other hand, can lead to the development and progression of cancer.
The specific project you will be involved in aims to further elucidate the functionality of SOX2, whose molecular regulation is a long-standing interest of the lab and which we recently discovered to be involved not only in transcription, but also in translation (i.e., protein synthesis by ribosomes, see Schaefer et al., Cell Reports 2024). This discovery may spur further advances in reprogramming technology and lead to new therapeutic approaches in reproductive and cancer medicine.